Ownership and insider activity for Penumbra, Inc. (PEN): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.
Price
| Price | $318.95 (closing price, October 30, 2026) |
| Market Cap | $12.6B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-15 | Narayan Shruthi | F-InKind | 1,230 | $392K |
| 2026-08-17 | Narayan Shruthi | A-Award | 3,060 | |
| 2026-05-19 | Elsesser Adam | G-Gift | 77,000 | |
| 2026-04-02 | Grewal Harpreet | S-Sale | 100 | $33K |
| 2026-03-15 | Narayan Shruthi | F-InKind | 117 | $39K |
| 2026-03-15 | Roberts Johanna | F-InKind | 186 | $63K |
| 2026-03-15 | Yuen Maggie | F-InKind | 186 | $63K |
| 2026-03-15 | Shiu Lambert | F-InKind | 150 | $50K |
| 2026-03-02 | Yuen Maggie | S-Sale | 2,432 | $832K |
| 2026-02-13 | Grewal Harpreet | A-Award | 589 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13.2M | $50.6M | $67.8M | $72.8M | $69.7M | $59.4M | $69.9M | $167.5M | $324.4M | $186.9M |
| Short-term Investments | $115.5M | $164.0M | $133.0M | $116.6M | $195.2M | $195.5M | $118.2M | $121.7M | $15.7M | $357.9M |
| Receivables | $43.3M | $58.0M | $81.9M | $105.9M | $114.6M | $133.9M | $203.4M | $201.8M | $167.7M | $190.0M |
| Inventory | $73.0M | $94.9M | $115.7M | $153.0M | $219.5M | $263.5M | $334.0M | $388.0M | $406.7M | $431.5M |
| Total Current Assets | $263.8M | $382.2M | $410.7M | $463.1M | $617.7M | $681.5M | $755.7M | $915.4M | $951.1M | $1.22B |
| Property, Plant & Equipment | $21.5M | $30.9M | $35.4M | $135.5M | $127.4M | $227.1M | $280.4M | $280.5M | $267.8M | $316.4M |
| Goodwill | 0 | $8.2M | $7.8M | $7.7M | $8.4M | $166.4M | $166.0M | $166.3M | $165.8M | $166.8M |
| Intangible Assets | 0 | $23.8M | $27.2M | $25.4M | $10.6M | $90.6M | $91.7M | $83.1M | $7.2M | $6.8M |
| Total Assets | $308.3M | $476.7M | $515.0M | $665.9M | $823.0M | $1.24B | $1.37B | $1.56B | $1.53B | $1.83B |
| Accounts Payable | $4.1M | $6.8M | $8.2M | $15.1M | $14.1M | $13.4M | $26.7M | $27.2M | $31.3M | $34.7M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $35.8M | $51.6M | $66.1M | $91.0M | $105.9M | $123.2M | $144.9M | $151.1M | $158.3M | $183.1M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $41.7M | $76.3M | $92.6M | $180.3M | $185.2M | $290.3M | $372.0M | $377.4M | $382.2M | $398.9M |
| Retained Earnings | -$2.7M | $2.0M | $9.1M | $57.5M | $40.6M | $45.9M | $43.9M | $134.9M | $60.0M | $237.7M |
| Total Equity | $266.5M | $400.4M | $422.2M | $485.9M | $641.5M | $953.9M | $998.9M | $1.18B | $1.15B | $1.43B |
| Total Debt | 0 | 0 | 0 | $82.3M | $77.3M | $173.5M | $235.8M | $234.3M | $223.4M | $219.7M |
| Net Debt | -$128.8M | -$214.6M | -$200.9M | -$107.1M | -$187.6M | -$81.3M | $47.7M | -$54.8M | -$116.7M | -$325.1M |
| Working Capital | $228.0M | $330.7M | $344.7M | $372.1M | $511.8M | $558.3M | $610.8M | $764.3M | $792.8M | $1.03B |
Financial Health
| Debt / Equity | 0.13 |
| Current Ratio | 5.89 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 20.17 |
Profitability
| Return on Equity | 10.44% |
| Return on Invested Capital | 7.91% |
| Return on Assets | 7.75% |
| Gross Margin | 67.98% |
| Operating Margin | 12.13% |
| Net Margin | 10.06% |
Related companies: BSX · ISRG · MMSI · ABT · MDT · EW
Explore sector: Healthcare · Medical - Devices
More sections of PEN: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks